BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9112565)

  • 1. Quantitative analysis of NM23 protein immunoreactivity in renal cell carcinoma using an image analyzer.
    Urakami S; Igawa M; Shirakawa H; Shiina H; Kawanishi M
    J Urol; 1997 May; 157(5):1928-31. PubMed ID: 9112565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoreactivity of nm23-H1 protein in renal cell carcinoma.
    Kuo JY; Chang KM; Chen KK; Chang LS
    Anticancer Res; 1998; 18(1B):531-6. PubMed ID: 9568173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated nm23 protein expression is correlated with diminished progression-free survival in patients with epithelial ovarian carcinoma.
    Srivatsa PJ; Cliby WA; Keeney GL; Dodson MK; Suman VJ; Roche PC; Podratz KC
    Gynecol Oncol; 1996 Mar; 60(3):363-72. PubMed ID: 8774640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. nm23-H1 protein immunoreactivity in laryngeal carcinoma.
    Lee CS; Redshaw A; Boag G
    Cancer; 1996 Jun; 77(11):2246-50. PubMed ID: 8635091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. nm23 protein expression in colorectal carcinoma metastasis in regional lymph nodes and the liver.
    Sarris M; Lee CS
    Eur J Surg Oncol; 2001 Mar; 27(2):170-4. PubMed ID: 11289754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma].
    Liu Y; Chen X; Peng S; Fang H; Wu Y; Peng C; Shi L; Bai M; Xu B; Wang J; Deng G
    Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1553-6. PubMed ID: 12609066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical analysis of nm23-H1 protein in bladder cancer.
    Kuo JY; Chiang H; Chen KK; Chang LS
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jul; 62(7):411-7. PubMed ID: 10418173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of nm23-H1 gene product in sarcomatous cancer cells of renal cell carcinoma: correlation with tumor stage and expression of matrix metalloproteinase-2, matrix metalloproteinase-9, sialyl Lewis X, and c-erbB-2.
    Ohba K; Miyata Y; Koga S; Kanda S; Kanetake H
    Urology; 2005 May; 65(5):1029-34. PubMed ID: 15882758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of nm23-H1 in transitional cell carcinoma of the upper urinary tract.
    Cheng HL; Tong YC; Tzai TS; Weng CL; Ho CL; Yang WH; Lin JS; Chow NH
    Oncol Rep; 2001; 8(1):193-6. PubMed ID: 11115597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NM23-H1 and NM23-H2 gene expression in human renal tumors.
    Theisinger B; Engel M; Seifert M; Seitz G; Welter C
    Anticancer Res; 1998; 18(2A):1185-9. PubMed ID: 9615786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on expression of nm23-H1 gene in laryngeal cancer tissues].
    Wang Q; Guo M; Sun L
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1996; 31(4):198-200. PubMed ID: 9642340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of nm23 antimetastatic gene product in parathyroid hyperplasia, adenoma and carcinoma. An immunohistological assessment.
    Al-Maghrabi JA; Asa SL
    Saudi Med J; 2005 May; 26(5):728-31. PubMed ID: 15951858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of nm23-H1 in the progression of transitional cell bladder cancer.
    Chow NH; Liu HS; Chan SH
    Clin Cancer Res; 2000 Sep; 6(9):3595-9. PubMed ID: 10999750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma.
    Tomić S; Ilić Forko J; Babić D; Sundov D; Kuret S; Andelinović S
    Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase activity and Nm23-H2 protein expression in hepatocellular carcinoma.
    Iizuka N; Mori N; Tamesa T; Tangoku A; Oka M
    Anticancer Res; 2003; 23(1A):43-7. PubMed ID: 12680194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of nm23-H1 gene in oral squamous cell carcinoma and its relation to tumor metastasis].
    Zhang T; Lai Q; Du D; Zhao Y; Chai J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Feb; 21(1):19-24. PubMed ID: 12569635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study.
    Bazan V; Migliavacca M; Zanna I; Tubiolo C; Corsale S; Calò V; Amato A; Cammareri P; Latteri F; Grassi N; Fulfaro F; Porcasi R; Morello V; Nuara RB; Dardanoni G; Salerno S; Valerio MR; Dusonchet L; Gerbino A; Gebbia N; Tomasino RM; Russo A
    J Cancer Res Clin Oncol; 2002 Dec; 128(12):650-8. PubMed ID: 12474051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of Nm23/NDPK expression in breast carcinoma, assessed on 10-year follow-up by automated and quantitative immunocytochemical assays.
    Charpin C; Garcia S; Bonnier P; Martini F; Andrac L; Horschowski N; Lavaut MN; Allasia C
    J Pathol; 1998 Apr; 184(4):401-7. PubMed ID: 9664906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of both NM23-h1 and NM23-H2 expression identifies "at-risk" patients with colorectal cancer.
    Brenner AS; Thebo JS; Senagore AJ; Duepree HJ; Gramlich T; Ormsby A; Lavery IC; Fazio VW
    Am Surg; 2003 Mar; 69(3):203-8; discussion 208. PubMed ID: 12678475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of nm23 protein in adult soft tissue sarcoma is correlated with histological grade.
    D'Souza RJ; Sheikh ZA; Busund LT; Russell PJ; Crowe PJ; Yang JL
    Anticancer Res; 2003; 23(4):3289-94. PubMed ID: 12926065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.